RAPT Therapeutics, Inc. Operating Income
RAPT Therapeutics, Inc. reported Operating Income of -$19.37 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2025-11-06
- RAPT Therapeutics, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$19.37M.
- RAPT Therapeutics, Inc. operating income (loss) for the quarter ending 2025-06-30 was -$19.54M.
- RAPT Therapeutics, Inc. operating income (loss) for the quarter ending 2025-03-31 was -$19.27M.
- RAPT Therapeutics, Inc. operating income (loss) for the quarter ending 2024-12-31 was -$54.47M.
- RAPT Therapeutics, Inc. operating income (loss) for fiscal 2024 was -$136.10M.
- RAPT Therapeutics, Inc. operating income (loss) for fiscal 2023 was -$127.06M.
- RAPT Therapeutics, Inc. operating income (loss) for fiscal 2022 was -$85.80M.
- RAPT Therapeutics, Inc. operating income (loss) for fiscal 2021 was -$69.21M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$19.37M 10-Q · filed 2025-11-06 | -$38.91M derived: sum of 2 quarters · filed 2025-11-06 | -$58.17M 10-Q · filed 2025-11-06 | -$112.64M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | -$19.54M 10-Q · filed 2025-08-07 | -$38.80M 10-Q · filed 2025-08-07 | -$93.27M derived: sum of 3 quarters · filed 2025-08-07 | -$113.05M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-03-31 | -$19.27M 10-Q · filed 2025-05-08 | -$73.73M derived: sum of 2 quarters · filed 2025-05-08 | -$93.52M derived: sum of 3 quarters · filed 2025-11-06 | -$122.85M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-12-31 | -$54.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$74.25M derived: sum of 2 quarters · filed 2025-11-06 | -$103.58M derived: sum of 3 quarters · filed 2025-11-06 | -$136.10M 10-K · filed 2025-03-06 |
| 2024-09-30 | -$19.79M 10-Q · filed 2025-11-06 | -$49.12M derived: sum of 2 quarters · filed 2025-11-06 | -$81.64M 10-Q · filed 2025-11-06 | -$114.85M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$29.33M 10-Q · filed 2025-08-07 | -$61.85M 10-Q · filed 2025-08-07 | -$95.06M derived: sum of 3 quarters · filed 2025-08-07 | -$128.98M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$32.52M 10-Q · filed 2025-05-08 | -$65.73M derived: sum of 2 quarters · filed 2025-05-08 | -$99.65M derived: sum of 3 quarters · filed 2025-05-08 | -$128.02M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$33.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$67.14M derived: sum of 2 quarters · filed 2025-03-06 | -$95.50M derived: sum of 3 quarters · filed 2025-03-06 | -$127.06M 10-K · filed 2025-03-06 |
| 2023-09-30 | -$33.92M 10-Q · filed 2024-11-12 | -$62.28M derived: sum of 2 quarters · filed 2024-11-12 | -$93.84M 10-Q · filed 2024-11-12 | -$118.28M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$28.36M 10-Q · filed 2024-08-08 | -$59.93M 10-Q · filed 2024-08-08 | -$84.36M derived: sum of 3 quarters · filed 2024-08-08 | -$106.03M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$31.56M 10-Q · filed 2024-05-09 | -$55.99M derived: sum of 2 quarters · filed 2024-05-09 | -$77.67M derived: sum of 3 quarters · filed 2024-05-09 | -$96.58M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$24.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$46.11M derived: sum of 2 quarters · filed 2024-03-07 | -$65.02M derived: sum of 3 quarters · filed 2024-03-07 | -$85.80M 10-K · filed 2024-03-07 |
| 2022-09-30 | -$21.68M 10-Q · filed 2023-11-13 | -$40.59M derived: sum of 2 quarters · filed 2023-11-13 | -$61.36M 10-Q · filed 2023-11-13 | -$79.40M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$18.91M 10-Q · filed 2023-08-11 | -$39.69M 10-Q · filed 2023-08-11 | -$57.72M derived: sum of 3 quarters · filed 2023-08-11 | -$76.25M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$20.78M 10-Q · filed 2023-05-11 | -$38.81M derived: sum of 2 quarters · filed 2023-05-11 | -$57.34M derived: sum of 3 quarters · filed 2023-05-11 | -$73.42M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$18.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$36.57M derived: sum of 2 quarters · filed 2023-03-14 | -$52.65M derived: sum of 3 quarters · filed 2023-03-14 | -$69.21M 10-K · filed 2023-03-14 |
| 2021-09-30 | -$18.53M 10-Q · filed 2022-11-10 | -$34.61M derived: sum of 2 quarters · filed 2022-11-10 | -$51.17M 10-Q · filed 2022-11-10 | -$64.26M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$16.08M 10-Q · filed 2022-08-11 | -$32.64M 10-Q · filed 2022-08-11 | -$45.73M derived: sum of 3 quarters · filed 2022-08-11 | -$60.31M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$16.56M 10-Q · filed 2022-05-11 | -$29.65M derived: sum of 2 quarters · filed 2022-05-11 | -$44.23M derived: sum of 3 quarters · filed 2022-05-11 | -$56.74M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$13.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$27.67M derived: sum of 2 quarters · filed 2022-03-10 | -$40.18M derived: sum of 3 quarters · filed 2022-03-10 | -$53.21M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$14.58M 10-Q · filed 2021-11-10 | -$27.09M derived: sum of 2 quarters · filed 2021-11-10 | -$40.13M 10-Q · filed 2021-11-10 | -$52.94M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$12.51M 10-Q · filed 2021-08-11 | -$25.55M 10-Q · filed 2021-08-11 | -$38.36M derived: sum of 3 quarters · filed 2021-08-11 | -$48.68M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$13.04M 10-Q · filed 2021-05-11 | -$25.85M derived: sum of 2 quarters · filed 2021-05-11 | -$36.17M derived: sum of 3 quarters · filed 2021-05-11 | -$47.13M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$12.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$23.13M derived: sum of 2 quarters · filed 2021-03-11 | -$34.09M derived: sum of 3 quarters · filed 2021-03-11 | -$43.63M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$10.31M 10-Q · filed 2020-11-16 | -$21.27M derived: sum of 2 quarters · filed 2020-11-16 | -$30.81M 10-Q · filed 2020-11-16 | -$40.49M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | -$10.96M 10-Q · filed 2020-08-13 | -$20.50M 10-Q · filed 2020-08-13 | -$30.17M derived: sum of 3 quarters · filed 2020-08-13 | -$40.72M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | -$9.54M 10-Q · filed 2020-05-14 | -$19.21M derived: sum of 2 quarters · filed 2020-05-14 | -$29.76M derived: sum of 3 quarters · filed 2020-05-14 | |
| 2018-12-31 | -$9.67M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$20.22M derived: sum of 2 quarters · filed 2020-03-30 | -$36.95M 10-K · filed 2020-03-30 | |
| 2018-09-30 | -$10.54M 10-Q · filed 2019-12-11 | -$27.28M 10-Q · filed 2019-12-11 |